One of the most exciting areas of medical innovation today is mobile health - "mHealth". Of course, innovation breeds regulation, and the Food and Drug Administration (FDA) has stepped in to this emerging market. In September, the FDA released its final guidance on mobile medical apps.
The idea of the FDA regulating iPhone apps is pretty alarming: The FDA adds precious years and dollars to the costs of developing new medical devices. Led by Representative Marsha Blackburn (R-TN), a bipartisan group of lawmakers wants to eliminate the risk of that happening to mHealth apps.
Read the entire article at Forbes.com's The Apothecary.
Research and commentary from a former senior executive in the U.S. Department of Health & Human Services
No comments:
Post a Comment